-
of Masaryk University in Brno was established on 1 January 2024 and focuses on research and development of cell and gene therapy for selected rare diseases. The CZECRIN Large Research Infrastructure (LRI) is
-
to ATMP research within the already established Research Group on ATMPs for Rare Diseases, led by Prof. Lenka Zdražilová Dubská. You can find out more about us on our websites: https://creatic.muni.cz
Enter an email to receive alerts for cellular "https:" positions